Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Observed Length Increases of Magnetically Controlled Growing Rods are Lower Than Programmed.

Gilday SE, Schwartz MS, Bylski-Austrow DI, Glos DL, Schultz L, O'Hara S, Jain VV, Sturm PF.

J Pediatr Orthop. 2018 Mar;38(3):e133-e137. doi: 10.1097/BPO.0000000000001119.

PMID:
29319661
2.

Translabyrinthine microsurgical resection of small vestibular schwannomas.

Schwartz MS, Lekovic GP, Miller ME, Slattery WH, Wilkinson EP.

J Neurosurg. 2017 Aug 18:1-9. doi: 10.3171/2017.2.JNS162287. [Epub ahead of print]

PMID:
28820301
3.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer.

Rowe PC, Underhill RA, Friedman KJ, Gurwitt A, Medow MS, Schwartz MS, Speight N, Stewart JM, Vallings R, Rowe KS.

Front Pediatr. 2017 Jun 19;5:121. doi: 10.3389/fped.2017.00121. eCollection 2017. Review.

4.

'Compassionate use' protocol for auditory brainstem implantation in neurofibromatosis type 2: Early House Ear Institute experience.

Roberts DS, Slattery WH, Chen BS, Otto SR, Schwartz MS, Lekovic GP.

Cochlear Implants Int. 2017 Jan;18(1):57-62. doi: 10.1080/14670100.2016.1258203. Epub 2017 Jan 18.

PMID:
28098509
5.

Initial Results of a Safety and Feasibility Study of Auditory Brainstem Implantation in Congenitally Deaf Children.

Wilkinson EP, Eisenberg LS, Krieger MD, Schwartz MS, Winter M, Glater JL, Martinez AS, Fisher LM, Shannon RV; Los Angeles Pediatric ABI Team.

Otol Neurotol. 2017 Feb;38(2):212-220. doi: 10.1097/MAO.0000000000001287.

6.

Tinnitus Suppression After Auditory Brainstem Implantation in Patients With Neurofibromatosis Type-2.

Roberts DS, Otto S, Chen B, Peng KA, Schwartz MS, Brackmann DE, House JW.

Otol Neurotol. 2017 Jan;38(1):118-122.

PMID:
27755361
7.

Auditory brainstem implant program development.

Schwartz MS, Wilkinson EP.

Laryngoscope. 2017 Aug;127(8):1909-1915. doi: 10.1002/lary.26312. Epub 2016 Sep 26. Review.

PMID:
27716925
8.

Consensus statement: Long-term results of ABI in children with complex inner ear malformations and decision making between CI and ABI.

Sennaroğlu L, Colletti V, Lenarz T, Manrique M, Laszig R, Rask-Andersen H, Göksu N, Offeciers E, Saeed S, Behr R, Bayazıt Y, Casselman J, Freeman S, Kileny P, Lee DJ, Shannon RV, Kameswaran M, Hagr A, Zarowski A, Schwartz MS, Bilginer B, Kishore A, Sennaroğlu G, Yücel E, Saraç S, Ataş A, Colletti L, O'Driscoll M, Moon IS, Gärtner L, Huarte A, Nyberg G, Mocan BÖ, Atay G, Bajin MD, Çınar BÇ, Batuk MÖ, Yaralı M, Aydınlı FE, Aslan F, Kirazlı MC, Özkan HB, Hans JM, Kosaner J, Polak M.

Cochlear Implants Int. 2016 Jul;17(4):163-171. Epub 2016 Jul 21. No abstract available.

PMID:
27442073
9.

Hearing Outcomes after Middle Fossa or Retrosigmoid Craniotomy for Vestibular Schwannoma Tumors.

Wilkinson EP, Roberts DS, Cassis A, Schwartz MS.

J Neurol Surg B Skull Base. 2016 Aug;77(4):333-40. doi: 10.1055/s-0035-1571166. Epub 2016 Feb 13.

10.

Multifocal granulocytic sarcoma of the spine mimicking neurofibromatosis Type 2: case report.

Lekovic GP, Schwartz MS, Go JL.

J Neurosurg Spine. 2016 Oct;25(4):523-527. Epub 2016 May 13.

PMID:
27176110
12.

Cerebellopontine angle and intracanalicular masses mimicking vestibular schwannomas.

Calzada AP, Go JL, Tschirhart DL, Brackmann DE, Schwartz MS.

Otol Neurotol. 2015 Mar;36(3):491-7. doi: 10.1097/MAO.0000000000000567.

PMID:
25226376
13.

Auditory brainstem implants in neurofibromatosis Type 2.

Schwartz MS.

J Neurosurg. 2014 Sep;121(3):760-1. doi: 10.3171/2014.3.JNS14490. Epub 2014 Jul 4. No abstract available.

PMID:
24995787
14.

Translabyrinthine resection of neurofibromatosis type 2 associated vestibular and facial schwannomas, repair of facial nerve, and placement of auditory brainstem implant.

Schwartz MS, Lekovic GP, Brackmann DE, Voelker CC.

Neurosurg Focus. 2014 Jan;36(1 Suppl):1. doi: 10.3171/2014.V1.FOCUS13429.

PMID:
24380525
15.

Evaluation of the increased use of partial resection of large vestibular schwanommas: facial nerve outcomes and recurrence/regrowth rates.

Schwartz MS, Kari E, Strickland BM, Berliner K, Brackmann DE, House JW, Friedman RA.

Otol Neurotol. 2013 Oct;34(8):1456-64. doi: 10.1097/MAO.0b013e3182976552.

PMID:
23928516
16.

The approach to the patient with incidentally diagnosed vestibular schwannoma.

Hoa M, Drazin D, Hanna G, Schwartz MS, Lekovic GP.

Neurosurg Focus. 2012 Sep;33(3):E2. doi: 10.3171/2012.6.FOCUS12209. Review.

PMID:
22937853
17.

In vitro activity of MK-7655, a novel β-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria.

Hirsch EB, Ledesma KR, Chang KT, Schwartz MS, Motyl MR, Tam VH.

Antimicrob Agents Chemother. 2012 Jul;56(7):3753-7. doi: 10.1128/AAC.05927-11. Epub 2012 Apr 23.

18.

Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia.

Li J, Chen J, Ricupero CL, Hart RP, Schwartz MS, Kusnecov A, Herrup K.

Nat Med. 2012 May;18(5):783-90. doi: 10.1038/nm.2709.

19.

Lack of causal association between spontaneous intracranial hypotension and cranial cerebrospinal fluid leaks.

Schievink WI, Schwartz MS, Maya MM, Moser FG, Rozen TD.

J Neurosurg. 2012 Apr;116(4):749-54. doi: 10.3171/2011.12.JNS111474. Epub 2012 Jan 20.

PMID:
22264184
20.

Quantitative determination of odanacatib in human plasma using liquid-liquid extraction followed by liquid chromatography-tandem mass spectrometry analysis.

Sun L, Forni S, Schwartz MS, Breidinger S, Woolf EJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Feb 15;885-886:15-23. doi: 10.1016/j.jchromb.2011.12.004. Epub 2011 Dec 13.

PMID:
22230741
21.

Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.

Friedman RA, Goddard JC, Wilkinson EP, Schwartz MS, Slattery WH 3rd, Fayad JN, Brackmann DE.

Otol Neurotol. 2011 Dec;32(9):1530-7. doi: 10.1097/MAO.0b013e3182355855.

PMID:
21986931
22.

Evolution in the management of facial nerve schwannoma.

Wilkinson EP, Hoa M, Slattery WH 3rd, Fayad JN, Friedman RA, Schwartz MS, Brackmann DE.

Laryngoscope. 2011 Oct;121(10):2065-74. doi: 10.1002/lary.22141. Epub 2011 Sep 6.

PMID:
21898431
23.

A paradigm shift in salvage surgery for radiated vestibular schwannoma.

Friedman RA, Berliner KI, Bassim M, Ursick J, Slattery WH 3rd, Schwartz MS, Brackmann DE.

Otol Neurotol. 2011 Oct;32(8):1322-8. doi: 10.1097/MAO.0b013e31822e5b76.

PMID:
21897324
24.

Middle fossa decompression for hearing preservation: a review of institutional results and indications.

Slattery WH, Hoa M, Bonne N, Friedman RA, Schwartz MS, Fisher LM, Brackmann DE.

Otol Neurotol. 2011 Aug;32(6):1017-24. doi: 10.1097/MAO.0b013e3182267eb7.

PMID:
21725256
25.

Development of a safety awareness group intervention for women with diverse disabilities: a pilot study.

Hughes RB, Robinson-Whelen S, Pepper AC, Gabrielli J, Lund EM, Legerski J, Schwartz MS.

Rehabil Psychol. 2010 Aug;55(3):263-71. doi: 10.1037/a0019916.

PMID:
20804270
26.

Fundal fluid as a predictor of hearing preservation in the middle cranial fossa approach for vestibular schwannoma.

Goddard JC, Schwartz MS, Friedman RA.

Otol Neurotol. 2010 Sep;31(7):1128-34. doi: 10.1097/MAO.0b013e3181e8fc3f.

PMID:
20657334
27.

Trigeminal neuralgia resulting from auditory brainstem implant cable compression.

Schwartz MS, Brackmann DE, Wilkinson EP, Go JL, Santos F.

J Neurosurg. 2011 Jan;114(1):186-8. doi: 10.3171/2010.5.JNS091709. Epub 2010 Jun 11.

PMID:
20540600
28.

Muscle contributions to support and progression during single-limb stance in crouch gait.

Steele KM, Seth A, Hicks JL, Schwartz MS, Delp SL.

J Biomech. 2010 Aug 10;43(11):2099-105. doi: 10.1016/j.jbiomech.2010.04.003. Epub 2010 May 20.

29.

Detoxification of multiple heavy metals by a half-molecule ABC transporter, HMT-1, and coelomocytes of Caenorhabditis elegans.

Schwartz MS, Benci JL, Selote DS, Sharma AK, Chen AG, Dang H, Fares H, Vatamaniuk OK.

PLoS One. 2010 Mar 5;5(3):e9564. doi: 10.1371/journal.pone.0009564.

30.

Treatment of recurrent and residual glomus jugulare tumors.

Fayad JN, Schwartz MS, Brackmann DE.

Skull Base. 2009 Jan;19(1):92-8. doi: 10.1055/s-0028-1103130.

31.

Type 2 diabetes mellitus in childhood: obesity and insulin resistance.

Schwartz MS, Chadha A.

J Am Osteopath Assoc. 2008 Sep;108(9):518-24. Review.

PMID:
18806081
32.

Cortical processing of respiratory occlusion stimuli in children with central hypoventilation syndrome.

Huang J, Marcus CL, Bandla P, Schwartz MS, Pepe ME, Samuel JM, Panitch HB, Bradford RM, Mosse YP, Maris JM, Colrain IM.

Am J Respir Crit Care Med. 2008 Oct 1;178(7):757-64. doi: 10.1164/rccm.200804-606OC. Epub 2008 Jul 24.

33.

Effect of sleep stage on breathing in children with central hypoventilation.

Huang J, Colrain IM, Panitch HB, Tapia IE, Schwartz MS, Samuel J, Pepe M, Bandla P, Bradford R, Mosse YP, Maris JM, Marcus CL.

J Appl Physiol (1985). 2008 Jul;105(1):44-53. doi: 10.1152/japplphysiol.01269.2007. Epub 2008 May 22.

34.

Auditory brainstem implants.

Schwartz MS, Otto SR, Shannon RV, Hitselberger WE, Brackmann DE.

Neurotherapeutics. 2008 Jan;5(1):128-36. doi: 10.1016/j.nurt.2007.10.068. Review.

35.

Determination of sitagliptin in human urine and hemodialysate using turbulent flow online extraction and tandem mass spectrometry.

Zeng W, Musson DG, Fisher AL, Chen L, Schwartz MS, Woolf EJ, Wang AQ.

J Pharm Biomed Anal. 2008 Feb 13;46(3):534-42. Epub 2007 Nov 17.

PMID:
18096349
36.

Prevention and treatment of cerebrospinal fluid leak after translabyrinthine acoustic tumor removal.

Fayad JN, Schwartz MS, Slattery WH, Brackmann DE.

Otol Neurotol. 2007 Apr;28(3):387-90.

PMID:
17414045
37.

Shaveless brain surgery: safe, well tolerated, and cost effective.

Horgan MA, Kernan JC, Schwartz MS, Kellogg JX, McMenomey SO, Delashaw JB.

Skull Base Surg. 1999;9(4):253-8.

38.

Metastatic alveolar soft-part sarcoma of the intracranial skull base: case report.

Cohen DB, Jones DM, Fergus AH, Qian J, Schwartz MS.

Skull Base. 2002 Feb;12(1):33-8.

39.

Quality of life following acoustic neuroma surgery.

Schwartz MS, Riddle SA, Delashaw JB Jr, Horgan MA, Kellogg JX, McMenomey SO.

Neurosurg Focus. 1998 Sep 15;5(3):e3.

PMID:
17112220
40.

Moyamoya syndrome associated with cocaine abuse. Case report.

Schwartz MS, Scott RM.

Neurosurg Focus. 1998 Nov 15;5(5):e7.

PMID:
17112210
42.

CSNS Young Neurosurgeon Award: acoustic neuroma surgical cost and outcome by hospital volume.

Schwartz MS, Slattery WH, Oppenheimer M, Fisher LM.

Clin Neurosurg. 2005;52:359-65. No abstract available.

PMID:
16626094
43.

Behavioral assessment and treatment of pediatric headache.

Andrasik F, Schwartz MS.

Behav Modif. 2006 Jan;30(1):93-113.

PMID:
16330521
44.

Coincidence of multiple endocrine neoplasia type IIa and type 1 diabetes mellitus.

Wallerstein R, Aisenberg J, Kala GK, Omotoso O, Schwartz MS.

J Pediatr Endocrinol Metab. 2005 Sep;18(9):925-6. No abstract available.

PMID:
16279372
45.

Surgical salvage after failed irradiation for vestibular schwannoma.

Friedman RA, Brackmann DE, Hitselberger WE, Schwartz MS, Iqbal Z, Berliner KI.

Laryngoscope. 2005 Oct;115(10):1827-32.

PMID:
16222204
46.
47.

Acoustic neuroma surgical cost and outcome by hospital volume in California.

Slattery WH, Schwartz MS, Fisher LM, Oppenheimer M.

Otolaryngol Head Neck Surg. 2004 Jun;130(6):726-35.

PMID:
15195059
48.

The evolution of surgical approaches for posterior fossa meningiomas.

Shen T, Friedman RA, Brackmann DE, Slattery WH 3rd, Hitselberger WE, Schwartz MS, Fisher L.

Otol Neurotol. 2004 May;25(3):394-7.

PMID:
15129123
49.

Use of a multichannel auditory brainstem implant for neurofibromatosis type 2.

Schwartz MS, Otto SR, Brackmann DE, Hitselberger WE, Shannon RV.

Stereotact Funct Neurosurg. 2003;81(1-4):110-4.

PMID:
14742973
50.

Aggressive vestibular schwannomas with postoperative rapid growth: clinicopathological analysis of 15 cases.

Schwartz MS, Hitselberger WE.

Neurosurgery. 2003 Sep;53(3):786; author reply 786-7. No abstract available.

PMID:
12959105

Supplemental Content

Loading ...
Support Center